K. Fitzpatrick

Studies of the Pharmacokinetics and Metabolism of 4-Aminopropiophenone (PAPP) in Rats, Dogs and Cynomolgus Monkeys

J. Bright, T. Marrs, R. H. Inns, 1991, Human & experimental toxicology.

Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease

C. Brefel‐Courbon, C. Thalamas, A. Taylor, 1999, European Journal of Clinical Pharmacology.

Lack of a Pharmacokinetic Interaction at Steady State Between Ropinirole and L‐Dopa in Patients with Parkinson's Disease

M. Cyronak, S. Vakil, A. López-Gil, 1999, Pharmacotherapy.

Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

O. Rascol, J. Montastruc, C. Thalamas, 1998, British journal of clinical pharmacology.

Pharmacokinetics and Metabolism of the Prodrug DB289 (2,5-Bis[4-(N-methoxyamidino)phenyl]furan Monomaleate) in Rat and Monkey and Its Conversion to the Antiprotozoal/Antifungal Drug DB75 (2,5-Bis(4-guanylphenyl)furan Dihydrochloride)

D. Boykin, B. John, A. Mcburney, 2007, Drug Metabolism and Disposition.

Species differences in the pharmacokinetics and metabolism of reparixin in rat and dog

B. John, R. Anacardio, A. Mcburney, 2006, Xenobiotica; the fate of foreign compounds in biological systems.

The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease.

F. Stocchi, A. Taylor, A. López-Gil, 1999, British journal of clinical pharmacology.